10 results found
LACIS is a competition law firm which focuses on matters concerning competition law in Ukraine and the region Services include all aspects of…
CLACIS | Global | 9 Apr 2021
CLACIS discusses - BIG BUSINESS: where shall antitrust law stand?
Nowadays, the world witnesses a global concentration of capital. Even developed economies such as, for instance, the US, th…
CLACIS | European Union, USA | 9 Sep 2020
Antitrust Liability for Tacit Algorithmic Price Alignment in the EU and the US
Pricing algorithm is a computer program which monitors and/or sets prices and can be possessed and applied unilaterally by a business entity, can be…
CLACIS | Ukraine | 9 Sep 2020
BEPS Plan implementation in Ukraine: why a corporate restructuring can require a merger approval
On May 21, the President signed the Law No 466-IX "On amendments to the Tax Code of Ukraine regarding the improvement of tax administration, removal…
CLACIS | Ukraine | 9 Sep 2020
Имплементация BEPS в Украине: в каких случаях корпоративная реструктуризация требует предварительного разрешения АМКУ на концентрацию
21 мая 2020 года Президент Зеленский подписал Закон № 466-IX «О внесении изменений в Налоговый Кодекс Украины касательно усовершенствования…
CLACIS | Ukraine | 12 Jul 2019
Antitrust Implications of Using Pricing Algorithms
Apricing algorithm can be defined as a computer procedure which, based on a set of rules, solves certain pricing tasks. Pricing algorithms can be of…
CLACIS | Ukraine | 1 Oct 2015
Applying for new merger control amnesty
The Anti-monopoly Committee of Ukraine (AMC) recently approved regulations providing for a merger control amnesty in Ukraine. This means that if an undertaking has previously failed to obtain merger control approval for a transaction – whether domestic or foreign – then for a one-year period, starting from September 15 2015, the undertaking may apply to the AMC to obtain approval and face a......
CLACIS | European Union, Ukraine | 2 Jul 2015
Competition concerns arising from parallel imports in pharmaceutical market
The removal of obstacles to parallel imports has traditionally been the primary enforcement activity conducted by the EU authorities in the pharmaceutical sector. In light of the Ukrainian Anti-monopoly Committee's recent investigation of the pharmaceutical market, it is worth considering whether the same approach should be taken in Ukraine.
Previous page 1 Next page
